Literature DB >> 9491102

Short communication: cultivation of bloodstream forms of Trypanosoma brucei and T. evansi in a serum-free medium.

H Hirumi1, S Martin, K Hirumi, N Inoue, H Kanbara, A Saito, N Suzuki.   

Abstract

Bloodstream forms of Trypanosoma brucei and T. evansi have been cultivated in an axenic culture system by using Iscove's modified DMEM-based HMI-9 medium supplemental with bathocuproinedisulphonic acid, L-cysteine, hypoxanthine, 2-mercaptoethanol, pyruvate, thymidine and 10% fetal bovine or adult horse serum. We developed a serum-free medium (HMI-244) in which serum in HMI-9 was replaced by fatty acid-free bovine serum albumin, bovine alpha 2-macroglobulin, bovine beta-lipoprotein, d-biotin, retinol, beta-alanine, L-anserine nitrate salt, L-ornithine hydrochloride, O-phosphorylethanolamine, sarcosine, taurine, adenosine-5'-triphosphate, 2'-deoxycytidine-5'-monophosphate, 2'-deoxyguanosine-5'-monophosphate, and 5-methyltetrahydrofolic acid. Maximum cell densities and population doubling times were 2.6 x 10(6) cells/ml; 10.6 hours and 2.2 x 10(6) cells/ml; 10.9 hours for T. brucei and T. evansi, respectively. Bloodstream forms continued to proliferate in the serum-free cultures for more than 90 days and the trypomastigotes retained their morphological characteristics and infectivity to mice. If validated, this serum-free medium may help reduce future interlaboratory variability in biochemical, immunological, molecular biological and drug sensitivity studies on these parasites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9491102     DOI: 10.1046/j.1365-3156.1997.d01-268.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  8 in total

1.  Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.

Authors:  Nicholas D Bland; Cuihua Wang; Craig Tallman; Alden E Gustafson; Zhouxi Wang; Trent D Ashton; Stefan O Ochiana; Gregory McAllister; Kristina Cotter; Anna P Fang; Lara Gechijian; Norman Garceau; Rajiv Gangurde; Ron Ortenberg; Mary Jo Ondrechen; Robert K Campbell; Michael P Pollastri
Journal:  J Med Chem       Date:  2011-11-08       Impact factor: 7.446

2.  Comparative efficacy of different in vitro cultivation media for Trypanosoma evansi isolated from different mammalian hosts inhabiting different geographical areas of India.

Authors:  Rajender Kumar; Jarnail Singh; Rubi Singh; Sanjay Kumar; S C Yadav
Journal:  J Parasit Dis       Date:  2013-05-23

Review 3.  Cultivation of clinically significant hemoflagellates.

Authors:  Frederick L Schuster; James J Sullivan
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

4.  Metabolomics guides rational development of a simplified cell culture medium for drug screening against Trypanosoma brucei.

Authors:  Darren J Creek; Brunda Nijagal; Dong-Hyun Kim; Federico Rojas; Keith R Matthews; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

5.  Application of crude and recombinant ELISAs and immunochromatographic test for serodiagnosis of animal trypanosomosis in the Umkhanyakude district of KwaZulu-Natal province, South Africa.

Authors:  Thu-Thuy Nguyen; Mono Sophie Motsiri; Moeti Oriel Taioe; Moses Sibusiso Mtshali; Yasuyuki Goto; Shin-Ichiro Kawazu; Oriel Matlhahane Molifi Thekisoe; Noboru Inoue
Journal:  J Vet Med Sci       Date:  2014-10-22       Impact factor: 1.267

6.  Antiparasitic Constituents of Beilschmiedia louisii and Beilschmiedia obscura and Some Semisynthetic Derivatives (Lauraceae).

Authors:  Christine C Waleguele; Brice M Mba'ning; Angelbert F Awantu; Jean J K Bankeu; Yannick S F Fongang; Augustin S Ngouela; Etienne Tsamo; Norbert Sewald; Bruno N Lenta; Rui W M Krause
Journal:  Molecules       Date:  2020-06-21       Impact factor: 4.411

7.  New Trypanosoma evansi Type B Isolates from Ethiopian Dromedary Camels.

Authors:  Hadush Birhanu; Tadesse Gebrehiwot; Bruno Maria Goddeeris; Philippe Büscher; Nick Van Reet
Journal:  PLoS Negl Trop Dis       Date:  2016-04-01

8.  Molecular Characterization of Trypanosoma evansi Mevalonate Kinase (TeMVK).

Authors:  Daniel P Duarte; Éden R Ferreira; Fabio M Lima; Franciane Batista; Michel De Groote; Eduardo Horjales; Luiz C Miletti; Diana Bahia
Journal:  Front Cell Infect Microbiol       Date:  2018-07-10       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.